Evidence map›Paper›PMID 42125259›Full record

ArticleMaterials today. Bio2026

A vitronectin-functionalized ECM-mimetic hydrogel platform for modelling integrin-dependent tumour responses to cilengitide.

Isaac Vieco-Martí, Sofia Granados-Aparici, Amparo López-Carrasco, Miguel F Segura, Manuel Salmerón-Sánchez, Inmaculada Noguera, Samuel Navarro, Rosa Noguera

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Isaac Vieco-MartíPathology Department, Medical School, University of Valencia-INCLIVA, Valencia, Spain.
Sofia Granados-ApariciPathology Department, Medical School, University of Valencia-INCLIVA, Valencia, Spain.
Amparo López-CarrascoPathology Department, Medical School, University of Valencia-INCLIVA, Valencia, Spain.
Miguel F SeguraChildhood Cancer and Blood Disorders Group, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, 08035, Spain.
Manuel Salmerón-SánchezCentre for the Cellular Microenvironment, Advanced Research Centre, University of Glasgow, Glasgow, UK.
Inmaculada NogueraPathology Department, Medical School, University of Valencia-INCLIVA, Valencia, Spain.
Samuel NavarroPathology Department, Medical School, University of Valencia-INCLIVA, Valencia, Spain.
Rosa NogueraPathology Department, Medical School, University of Valencia-INCLIVA, Valencia, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The extracellular matrix (ECM) critically regulates tumour cell adhesion, mechanotransduction and therapeutic response, yet there is a lack of

Indexed as

GelatineHydrogelNeuroblastomaSilkVitronectin

Identifiers

PMID42125259
PMCPMC13158391

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.